Duodenal gastrinoma - Clinical features and usefulness of selective arterial secretin injection test

Journal of Gastroenterology

Volumn 33, Issue 5, 1998, Pages 728-733

  Takasu, Atsuko ^a   Shimosegawa, Tooru ^a   Fukudo, Shin ^a   Asakura, Tohru ^a   Uchi, Midori ^a   Kimura, Kenji ^a   Kashimura, Junya ^a   Satoh, Kennichi ^a   Koizumi, Masaru ^a   Sasaki, Iwao ^a   Hongo, Michio ^a   Suzuki, Toshimitsu ^b   Toyota, Takayoshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Duodenal gastrinoma; Localization; SASI test; Secretin test; Zollinger Ellison syndrome

Indexed keywords

SECRETIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DUODENUM CANCER; GASTRINOMA; HUMAN; HYPERGASTRINEMIA; INTRAARTERIAL DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MALE; PALPATION; PANCREAS; PATHOLOGY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STOMACH ACID SECRETION; ZOLLINGER ELLISON SYNDROME;

DIAGNOSIS, DIFFERENTIAL; DUODENAL NEOPLASMS; GASTRINOMA; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; SECRETIN;

EID: 7344246042     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050163     Document Type: Article

References (30)

1. Thom AK, Norton JA, Axiotis CA, et al. Location, incidence, and malignant potential of duodenal gastrinomas. Surgery 1991;110:1086-1093.
2. Delcore R, Cheung LY, Friesen SR. Characteristics of duodenal wall gastrinomas. Am J Surg 1990;160:621-624.
3. Thompson NW, Vinik AI, Eckhauser FE. Microgastrinomas of the duodenum: A case of failed operations for the Zollinger-Ellison syndrome. Ann Surg 1989;209:396-404.
4. Weber HC, Venzon DJ, Norton JA, et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: A prospective long-term study. Gastroenterology 1995;108:1637-1649.
5. Imamura M, Takahashi K, Adachi H, et al. Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndrome. Ann Surg 1987;205:230-239.
6. Jensen RT, Gardner JD. Gastrinoma. In: Go VLW, Lebenthal E, DiMagno E, et al. (eds) The pancreas: Biology, pathobiology, and disease, 2nd ed. New York: Raven, 1993;931-978.
7. Solcia E, Capella C, Buffa R, et al. Pathology of the Zollinger-Ellison syndrome. Prog Surg Pathol 1980;1:119-133.
8. Solcia E, Capella C, Buffa R, et al. Endocrine cells of the gastrointestinal tract and related tumors. Pathol Ann 1979;9:163-204.
9. Friesen SR. Tumors of the endocrine pancreas. N Engl J Med 1982;306:580-590.
10. Norton JA, Doppman JL, Jensen RT. Curative resection in ZoUinger-Ellison syndrome: Results of a 10-year prospective study. Ann Surg 1992;215:8-18.
11. Delcore R, Friesen SR. Role of pancreatoduodenectomy in the management of primary duodenal wall gastrinomas in patients with Zollinger-Ellison Syndrome. Surgery 1992;112:1016-1021.
12. Wolfe MM, Jensen RT. Zollinger-Ellison syndrome: Current concepts in diagnosis and management. N Engl J Med 1987;317: 1200-1209.
13. Frucht H, Howard JM, Slaff JE, et al. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome: A prospective study. Ann Intern Med 1989;111:713-722.
14. Chiba T, Yamatani T, Yamaguchi A, et al. Mechanism for increase of gastrin release by secretin in Zollinger-Ellison syndrome. Gastroenterology 1989;96:1439-1444.
15. Elouaer-Blanc L, Sobhani I, Ruszniewski P, et al. Gastrin secretion by gastrinoma cells in long-term culture. Am J Physiol 1988;255:G596-602.
16. Sugg SL, Norton JA, Fraker DL, et al. A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas. Ann Surg 1993;218:138-144.
17. Frucht H, Norton JA, London JF, et al. Detection of duodenal gastrinomas by operative endoscopic transillumination: A prospective study. Gastroenterology 1990;99:1622-1627.
18. Maton PN, Miller DL, Doppman JL, et al. Role of selective angiography in the management of patients with Zollinger-Ellison syndrome. Gastroeneterology 1987;92:913-918.
19. Ruszniewski P, Amouyal P, Amouyal G, et al. Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Effison syndrome. Surgery 1995;117:629-635.
20. Jamer F, Fiasse R, Leners N, et al. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: Safety, efficacy and impact on patient management. J Nucl Med 1995;36:342-549.
21. Schirmer WJ, Melvin WS, Rush RM, et al. Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma. Surgery 1995;118:1105-1114.
22. Zimmer T, Ziegler K, Bäder M, et al. Localization of neuroendocrine tumors of the upper gastrointestinal tract. Gut 1994; 35:471-475.
23. Cadiot G, Lebtahi R, Sarda L, et al. Preoperative detection of duodenal gastrinoma and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Gastroenterology 1996; 111:845-854.
24. Thom AK, Norton JA, Doppman JL, et al. Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas. Surgery 1992;112: 1002-1009.
25. Wu WC, Kengis J, Whalen GE, et al. Endoscopic localization of a duodenal wall tumor in Zollinger-Ellison syndrome. Gastroenterology 1974;66:1237-1239.
26. Donovan DC, Dureza R, Jain U. Gastrinoma of duodenum: Diagnosis by endoscopy. NY State J Med 1979;79:1766-1768.
27. Otten MH, Birkenhager JC, Van Blankenstein M. Zollinger-Ellison syndrome treated by endoscopic removal of a duodenal gastrinoma. Neth J Med 1978;21:248-251.
28. Gilhool WJ. Endoscopic diagnosis and removal of a duodenal wall gastrinoma. Am J Gastroenterol 1984;79:679-683.
29. Wadas DD, Foutch PG, Manne RK, et al. Endoscopic diagnosis of a duodenal gastrinoma. Gastrointest Endosc 1988;34:430-431.
30. Pisegna JR, Norton JA, Slimak GG, et al. Effects of curative gastrinoma resection on gastric secretory function and anti-secretory drug requirement in the Zollinger-Ellison syndrome. Gastroenterology 1992;102:767-778.